1-hexylcarbamoyl-5-fluorouracil

Known as: 1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-, Carmofur, HCFU 
An antimetabolite (pyrimidine analogue) antineoplastic derivative of 5-fluorouracil. (NCI)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2017
0102019762017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Breast cancer is the second leading cause of cancer related deaths among females worldwide. Berbamine (BER), a kind of bis… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE The effectiveness of preoperative radiation therapy for advanced lower rectal carcinoma to preserve the function of… (More)
Is this relevant?
1989
1989
The synergic effects on HeLa cells between 1-hexylcarbamoyl-5-fluorouracil (HCFU), a lipophilic masked compound of 5-fluorouracil… (More)
Is this relevant?
1988
1988
The sensitivity of human gastric cancer tissue to 5-fluorouracil (5-FU) and its analogues 1-(2-tetrahydrofuryl)-5-fluorouracil… (More)
Is this relevant?
1988
1988
The sensitivity to 1-hexylcarbamoyl-5-fluorouracil (HCFU) of 25 colorectal cancer tissues was compared with that of six antitumor… (More)
Is this relevant?
1987
1987
The sensitivity of HeLa cells and 15 human tumors, including eight gastric cancers, five colorectal cancers and two lung cancers… (More)
Is this relevant?
1984
1984
1-Hexylcarbamoyl-5-fluorouracil (HCFU) was administered orally to 63 patients with hepatocellular carcinoma (HCC) at a daily dose… (More)
Is this relevant?
1981
1981
Excretion and metabolites in urine and feces of mice after oral administration of l-hexylcarbamoyl-5-fluorouracil-6-14C (14C-HCFU… (More)
Is this relevant?
1978
1978
1. The metabolic fate of a new antitumour agent, 1-hexylcarbamoyl-5-fluoro [6-14C]uracil (14C-HCFU) in rats after oral… (More)
Is this relevant?
1976
1976
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil against various tumors was examined. Therapeutic ratio (ILSmax/ILS30) in L… (More)
Is this relevant?